What is the Projected CAGR value of the Non-Invasive Prenatal Testing Market?
The non-Invasive Prenatal Testing Market is expected to grow at a CAGR of 18% during the forecasting period 2023-2030.
Which region accounted for the largest market share in the global non-invasive prenatal testing market?
North America region accounted for the largest market share in the global non-invasive prenatal testing market.
Who are the leading end users for the non-invasive prenatal testing market?
leading end users for the non-invasive prenatal testing market are Hospitals and Diagnostic Centers.
Who are the Key players contributing to the market's growth?
The Key Players are PerkinElmer, Inc, BGI, CENTOGENE AG, Eurofins Scientific, F. Hoffmann-La Roche Ltd, Invitae Corporation, Illumina, Inc., Natera, Inc., Progenity, Inc., Quest Diagnostics.